Martial Descoutures
Stock Analyst at Oddo BHF
(2.98)
# 2,739
Out of 4,662 analysts
17
Total ratings
77.8%
Success rate
14.5%
Average return
Main Sectors:
Stocks Rated by Martial Descoutures
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: ABVX ABIVAX Société Anonyme | Maintained: Buy | €120.00 | €103.30 | +16.17% | 1 | Apr 9, 2026 | |
| SWX: SDZ Sandoz Group AG | Initiated Coverage: Hold | CHF 57.00 | CHF 74.10 | -23.08% | 1 | Dec 18, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Downgraded: Hold | kr 910.00 → kr 465.00 | kr 299.18 | n/a | 2 | Jul 30, 2025 | |
| LON: 0NZT UCB SA | Upgraded: Buy | €107.00 → €168.00 | €218.75 | n/a | 2 | Jul 26, 2024 | |
| NVS Novartis AG | Downgraded: Hold | n/a | $159.88 | n/a | 2 | Mar 13, 2024 | |
| NVO Novo Nordisk | Downgraded: Hold | n/a | $46.47 | n/a | 1 | Mar 13, 2024 | |
| LON: GSK GSK plc | Upgraded: Buy | 1,490p → 1,700p | 1,916p | n/a | 2 | Sep 29, 2022 | |
| SWX: NOVN Novartis AG | Downgraded: Hold | CHF 93.00 → CHF 88.00 | CHF 127.12 | n/a | 2 | Sep 28, 2022 | |
| BIT: REC Recordati Industria Chimica e Farmaceutica S.p.A. | Upgraded: Hold | €42.00 | €53.05 | n/a | 2 | Jul 29, 2022 | |
| SWX: ROP Roche Holding AG | Upgraded: Buy | n/a | $367.40 | n/a | 1 | Mar 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €94.00 | €78.56 | n/a | 1 | Jul 29, 2019 |
ABIVAX Société Anonyme
Apr 9, 2026
Maintained: Buy
Price Target: €120.00
Current: €103.30
Upside: +16.17%
Sandoz Group AG
Dec 18, 2025
Initiated Coverage: Hold
Price Target: CHF 57.00
Current: CHF 74.10
Upside: -23.08%
Novo Nordisk A/S
Jul 30, 2025
Downgraded: Hold
Price Target: kr 910.00 → kr 465.00
Current: kr 299.18
Upside: n/a
UCB SA
Jul 26, 2024
Upgraded: Buy
Price Target: €107.00 → €168.00
Current: €218.75
Upside: n/a
Novartis AG
Mar 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $159.88
Upside: n/a
Novo Nordisk
Mar 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $46.47
Upside: n/a
GSK plc
Sep 29, 2022
Upgraded: Buy
Price Target: 1,490p → 1,700p
Current: 1,916p
Upside: n/a
Novartis AG
Sep 28, 2022
Downgraded: Hold
Price Target: CHF 93.00 → CHF 88.00
Current: CHF 127.12
Upside: n/a
Recordati Industria Chimica e Farmaceutica S.p.A.
Jul 29, 2022
Upgraded: Hold
Price Target: €42.00
Current: €53.05
Upside: n/a
Roche Holding AG
Mar 31, 2020
Upgraded: Buy
Price Target: n/a
Current: $367.40
Upside: n/a
Jul 29, 2019
Maintained: Buy
Price Target: €94.00
Current: €78.56
Upside: n/a